OOIR: Observatory of International Research

Papers

(The H4-Index of JAMA-Journal of the American Medical Association is 161. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian Randomization	1509
Diagnosis and Treatment of Metastatic Colorectal Cancer	1241
Diagnosis and Treatment of Hip and Knee Osteoarthritis	1023
Bladder Cancer	976
Screening for Colorectal Cancer	975
Screening for Lung Cancer	914
Updated Guidance on the Reporting of Race and Ethnicity in Medical and Science Journals	895
Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients	851
Pancreatic Cancer	846
Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19	797
Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults	659
Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19	636
The Leading Causes of Death in the US for 2020	634
Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk	622
Diagnosis and Treatment of Multiple Sclerosis	616
Donanemab in Early Symptomatic Alzheimer Disease	612
Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants	555
Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity	532
Racial and Ethnic Health Disparities Related to COVID-19	502
Genetic Variants of SARS-CoV-2—What Do They Mean?	500
Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity	490
Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the	488
Long-term Health Consequences of COVID-19	479
Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity	478
Surveillance for Adverse Events After COVID-19 mRNA Vaccination	467

Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021	462
Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021	454
Diagnosis and Management of Multiple Myeloma	451
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19	451
Prevalence and Treatment of Diabetes in China, 2013-2018	437
US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021	437
Diagnosis and Management of Infertility	436
Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes	436
Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients	434
Characteristics and Outcomes of Hospitalized Patients in South Africa During the COVID-19 Omicron Wave Compared With Previous Waves	428
Four-Month Clinical Status of a Cohort of Patients After Hospitalization for COVID-19	427
Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19	426
Acute Pancreatitis	395
Effect of Mechanical Thrombectomy Without vs With Intravenous Thrombolysis on Functional Outcome Among Patients With Acute Ischemic Stroke	386
Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma	383
Effect of a Single High Dose of Vitamin D₃ on Hospital Length of Stay in Patients With Moderate to Severe COVID-19	378
Effect of Endovascular Treatment Alone vs Intravenous Alteplase Plus Endovascular Treatment on Functional Independence in Patients With Acute Ischemic Stroke	371
Diagnosis and Management of Transient Ischemic Attack and Acute Ischemic Stroke	369
Older Adults and the Mental Health Effects of COVID-19	362
Effect of Intra-arrest Transport, Extracorporeal Cardiopulmonary Resuscitation, and Immediate Invasive Assessment and Treatment on Functional Neurologic Outcome in Refractory Out-of-Hospital Cardiac A	339
SARS-CoV-2 Vaccines	336
Glaucoma in Adults—Screening, Diagnosis, and Management	334
Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US—December 14, 2020-January 18, 2021	333
Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection	332
Comparison of SARS-CoV-2 Antibody Response Following Vaccination With BNT162b2 and mRNA-1273	331
Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19	320
Trends in Prevalence of Type 1 and Type 2 Diabetes in Children and Adolescents in the US, 2001-2017	320
Diagnosis and Treatment of Acute Coronary Syndromes	320
Immunogenicity of COVID-19 mRNA Vaccines in Pregnant and Lactating Women	318
Screening for Colorectal Cancer	315
Myocarditis and Pericarditis After Vaccination for COVID-19	312
Neonatal Abstinence Syndrome and Maternal Opioid-Related Diagnoses in the US, 2010-2017	309
Antibody Response After a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Kidney Transplant Recipients With Minimal Serologic Response to 2 Doses	306
The Quintuple Aim for Health Care Improvement	304
Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19	303
Mortality, In-Hospital Morbidity, Care Practices, and 2-Year Outcomes for Extremely Preterm Infants in the US, 2013-2018	300
Symptoms and Functional Impairment Assessed 8 Months After Mild COVID-19 Among Health Care Workers	300
Screening for Lung Cancer With Low-Dose Computed Tomography	299
SARS-CoV-2 Variants of Concern in the United States—Challenges and Opportunities	298
Effect of Helmet Noninvasive Ventilation vs High-Flow Nasal Oxygen on Days Free of Respiratory Support in Patients With COVID-19 and Moderate to Severe Hypoxemic Respiratory Failure	295
Intubation Practices and Adverse Peri-intubation Events in Critically Ill Patients From 29 Countries	295
Binding and Neutralization Antibody Titers After a Single Vaccine Dose in Health Care Workers Previously Infected With SARS-CoV-2	295
Effect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes	284
Trends in Prevalence of Diabetes and Control of Risk Factors in Diabetes Among US Adults, 1999-2018	283
Emergence of a Novel SARS-CoV-2 Variant in Southern California	279
Appropriateness of Cardiovascular Disease Prevention Recommendations Obtained From a Popular Online Chat-Based Artificial Intelligence Model	279
Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19	275
Reactogenicity Following Receipt of mRNA-Based COVID-19 Vaccines	269
A Proposed Framework and Timeline of the Spectrum of Disease Due to SARS-CoV-2 Infection	266
Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Persons	266

Glioblastoma and Other Primary Brain Malignancies in Adults	266
Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19	263
Association of Intravenous Immunoglobulins Plus Methylprednisolone vs Immunoglobulins Alone With Course of Fever in Multisystem Inflammatory Syndrome in Children	262
Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction	258
Screening for Prediabetes and Type 2 Diabetes	256
Diagnosis and Treatment of Pulmonary Arterial Hypertension	252
Effectiveness of Mask Wearing to Control Community Spread of SARS-CoV-2	251
Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine	248
Effect of Noninvasive Respiratory Strategies on Intubation or Mortality Among Patients With Acute Hypoxemic Respiratory Failure and COVID-19	246
What’s Wrong With Advance Care Planning?	243
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults	240
SARS-CoV-2–Specific Antibodies in Breast Milk After COVID-19 Vaccination of Breastfeeding Women	239
The Reporting of Race and Ethnicity in Medical and Science Journals	235
Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin	233
Effect of Sotrovimab on Hospitalization or Death Among High-risk Patients With Mild to Moderate COVID-19	231
COVID-19 as the Leading Cause of Death in the United States	229
Hearing Loss in Children	229
A Guideline for Reporting Mediation Analyses of Randomized Trials and Observational Studies	226
Estimates of SARS-CoV-2 Omicron Variant Severity in Ontario, Canada	224
Association Between BNT162b2 Vaccination and Incidence of SARS-CoV-2 Infection in Pregnant Women	224
National Trends in the US Public’s Likelihood of Getting a COVID-19 Vaccine—April 1 to December 8, 2020	224
Excess Deaths From COVID-19 and Other Causes in the US, March 1, 2020, to January 2, 2021	222
Five-Year Outcomes in Patients With Fully Magnetically Levitated vs Axial-Flow Left Ventricular Assist Devices in the MOMENTUM 3 Randomized Trial	219
Diabetic Foot Ulcers	216
Effect of Vitamin D Supplementation, Omega-3 Fatty Acid Supplementation, or a Strength-Training Exercise Program on Clinical Outcomes in Older Adults	214
Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis	214
Immortal Time Bias in Observational Studies	214
Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic L	212
Nonhuman “Authors” and Implications for the Integrity of Scientific Publication and Medical Knowledge	211
Changes in Body Mass Index Among Children and Adolescents During the COVID-19 Pandemic	210
Recalibrating the Use of Race in Medical Research	206
Guidelines for Reporting Outcomes in Trial Reports	205
Association of Convalescent Plasma Treatment With Clinical Outcomes in Patients With COVID-19	204
Target Trial Emulation	203
Alcohol-Related Deaths During the COVID-19 Pandemic	202
Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography	201
Association Between Depressive Symptoms and Incident Cardiovascular Diseases	200
Gastroesophageal Reflux Disease	198
Acute Allergic Reactions to mRNA COVID-19 Vaccines	196
Effect of Blinatumomab vs Chemotherapy on Event-Free Survival Among Children With High-risk First-Relapse B-Cell Acute Lymphoblastic Leukemia	195
Effect of Antithrombotic Therapy on Clinical Outcomes in Outpatients With Clinically Stable Symptomatic COVID-19	194
Autism Spectrum Disorder	194
Effect of Regional vs General Anesthesia on Incidence of Postoperative Delirium in Older Patients Undergoing Hip Fracture Surgery	187
Guidelines for Reporting Trial Protocols and Completed Trials Modified Due to the COVID-19 Pandemic and Other Extenuating Circumstances	187
SARS-CoV-2 Vaccines and the Growing Threat of Viral Variants	187
Association of Bariatric Surgery With Major Adverse Liver and Cardiovascular Outcomes in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis	186
Heart Failure With Preserved Ejection Fraction	185
Association Between BNT162b2 Vaccination and Long COVID After Infections Not Requiring Hospitalization in Health Care Workers	184
Effect of Vitamin C, Thiamine, and Hydrocortisone on Ventilator- and Vasopressor-Free Days in Patients With Sepsis	184
Diagnosis and Management of Lumbar Spinal Stenosis	184
Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers	183
COVID-19 and Excess All-Cause Mortality in the US and 18 Comparison Countries	182
Association Between Age at Diabetes Onset and Subsequent Risk of Dementia	182
Effect of High-Flow Oxygen Therapy vs Conventional Oxygen Therapy on Invasive Mechanical Ventilation and Clinical Recovery in Patients With Severe COVID-19	181
Aspirin Use to Prevent Cardiovascular Disease	181
Association of SARS-CoV-2 Infection With Serious Maternal Morbidity and Mortality From Obstetric Complications	180
Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia	180
AI-Generated Medical Advice—GPT and Beyond	179
Diagnosis and Treatment of Alcohol-Associated Liver Disease	179
Trends in Consumption of Ultraprocessed Foods Among US Youths Aged 2-19 Years, 1999-2018	179
Clinical Outcomes Among Patients With 1-Year Survival Following Intensive Care Unit Treatment for COVID-19	178
Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality	178
Diagnosis and Treatment of Irritable Bowel Syndrome	176
Colorectal Cancer Screening	176
Evaluating the Patient With a Pulmonary Nodule	175
Effect of High-Intensity Interval Training, Moderate Continuous Training, or Guideline-Based Physical Activity Advice on Peak Oxygen Consumption in Patients With Heart Failure With Preserved Ejection	174
Management of Crohn Disease	174
Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021	172
Readmission and Death After Initial Hospital Discharge Among Patients With COVID-19 in a Large Multihospital System	171
Psychological Distress and COVID-19–Related Stressors Reported in a Longitudinal Cohort of US Adults in April and July 2020	170
Winter of Omicron—The Evolving COVID-19 Pandemic	170
Association of Dose Tapering With Overdose or Mental Health Crisis Among Patients Prescribed Long-term Opioids	169
Antiseizure Medications for Adults With Epilepsy	169
Confronting the Delta Variant of SARS-CoV-2, Summer 2021	168
Effect of Bamlanivimab vs Placebo on Incidence of COVID-19 Among Residents and Staff of Skilled Nursing and Assisted Living Facilities	168
Cardiogenic Shock After Acute Myocardial Infarction	167
Spontaneous Abortion Following COVID-19 Vaccination During Pregnancy	166
Long-term Symptoms After SARS-CoV-2 Infection in Children and Adolescents	166
Sickle Cell Disease	166
Acute Cholecystitis	165

Evaluation of Aducanumab for Alzheimer Disease	164
Effect of Intra-arterial Alteplase vs Placebo Following Successful Thrombectomy on Functional Outcomes in Patients With Large Vessel Occlusion Acute Ischemic Stroke	163
Association of Bariatric Surgery With Cancer Risk and Mortality in Adults With Obesity	162
Monkeypox in 2022—What Clinicians Need to Know	162
Single Ascending Dose Study of a Short Interfering RNA Targeting Lipoprotein(a) Production in Individuals With Elevated Plasma Lipoprotein(a) Levels	162
SARS-CoV-2 Viral Variants—Tackling a Moving Target	162
Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer	161